A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Olpasiran in Chinese Participants With Elevated Serum Lipoprotein(a)
Clinical trial NCT04987320 · COMPLETED
Trial details
- NCT number
- NCT04987320
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-28
- Primary completion
- 2021-11-12
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.